Spencer Jones, founder and chief technology officer of Fayetteville-based Lineus Medical, joins Apophichsanother medical device company in Fayetteville.
Lapovations announced Tuesday (October 18) that Jones has joined the company that makes products to improve laparoscopy. He has been appointed as Chief Technology Officer and Vice President of Sales and will lead product innovation and sales and distribution of the company’s flagship product, AbGrab.
In 2015, Jones founded Linus Medicaland, as CTO, he led the company’s innovation and clinical efforts. During that time, Lineus Medical has taken the SafeBreak Vascular medical device from idea to clearance with the U.S. Food and Drug Administration (FDA) and has received multiple U.S. and international patents. Jones said August 31 was his last day at Lineus Medical.
“I’ve been a huge supporter of Lapovations since the company’s early days and have always been impressed by their track record of success,” said Jones. “I am very excited to join this fantastic team of operators and look forward to building on the momentum they have already created.”
Since 2020, Jones has been a part-time consultant to Lapovations and served as the company’s director of research and development, supporting product development and assisting with marketing, sales and distribution.
“Spencer has been a key advisor, albeit informal, to me since day one,” said Jared Greer, founder and CEO of Lapovations. “We’ve been fortunate to work with him more formally as a part-time consultant for several years now, and we couldn’t be happier at the opportunity to add him to our full-time executive team. If I could pick one medical device executive in Northwest Arkansas to partner with, it would be Spencer.” He has demonstrated managerial strength and is a true leader that employees and other key stakeholders can stand behind.I have worked with Spencer across many projects over the years and have witnessed the extent and depth of his experience.He is experienced, has great instincts and has what it takes to develop Lapovations into a company we know can to be “.
Over the past several months, Lapovations has acquired seven distribution partnerships, with 22 representatives selling AbGrab across 11 states. AbGrab is registered with the FDA and became available for sale in the United States in January 2021. Lapovations has five employees.
“We’ve made a lot of progress so far, but we’re still at the beginning,” Jones said. “Over the next year, we plan to include dozens of additional sales reps, with an emphasis on those with strong surgeon relationships in goal-rich environments. Preparing, supporting, and training distributors reps was an important part of working with my previous employer and something I distinguished and enjoyed.” Jared is a man An exceptional business who has achieved true sales excellence throughout his career, and I am grateful for the trust he has placed in me to lead the sales and distribution of Lapovations.”
According to a press release, the AbGrab is a surgical assistant device that allows surgeons to more reliably and less invasively raise the abdominal wall at the start of laparoscopy, or minimally invasive surgery. Although it is often the shortest part of the laparoscopic procedure, laparoscopic entry accounts for about half of the serious laparoscopic complications and litigation related to laparoscopy.
When asked about his involvement in Lineus Medical’s development of his invented devices, including a manifolded venous access device (BVAD) that has not yet received FDA clearance, Jones said, “I will not be involved in the development of BVAD going forward, but it is with a strong interest in seeing the product receive With a statement from the Food and Drug Administration, I am fully prepared to help further develop it in any way I can.”
Lineus Medical’s first medical device, SafeBreak Vascular, It received FDA clearance in May 2021.
“Lineus Medical has tripled in size in the last year since FDA approved our flagship SafeBreak Vascular product,” said Vance Clement, CEO of Lineus Medical. innovation and organizational development.
Asked if Jones’ move to another company would affect Lineus Medical, Clement noted that the company has had the same CEO for more than four years. “The company, along with the strong leadership team that has been put in place, will continue to implement the organization’s strategic plan,” he added.
Clement said the company, which has eight employees, does not plan to replace the chief technology officer role that Jones vacated.
“Spencer has an entrepreneurial spirit and founded Lineus Medical as a 24-year-old nurse and raised the first seed funding round necessary to start the company,” Clement said. “Lineus Medical would not have existed without this initial product idea and his efforts to revitalize and run the company. Spencer is a hardworking, tireless person who brings tremendous energy to the organization. He will do great things in his new role at Lapovations.”
In 2016, Lapovations was formed into the graduate-level New Entrepreneurial Development course taught jointly by Carol Reeves and Sarah Goforth with the Office of Entrepreneurship and Innovation at the University of Arkansas. According to the company’s website, Lapovations has become the most successful startup competition team in UA history, winning seven state, regional, and national business plan competitions, finishing second in two others and winning more than $305,000 in cash and investment prizes. The site states that the company has received more than $2.5 million in funding.